Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines today announced the US Food and Drug Administration FDA has approved the Biologics License Application BLA for SPIKEVAX COVID Vaccine mRNA to prevent COVID in...
Kite a Gilead Company today announced the US Food and Drug Administration FDA has approved an update to the prescribing information for Yescarta axicabtagene ciloleucel to include use of prophylactic corticosteroids across all approved indications Ye...
Roche announced that the US Food and Drug Administration FDA has approved Vabysmo faricimabsvoa for the treatment of neovascular or wet agerelated macular degeneration nAMD and diabetic macular edema DME Neovascular AMD and DME are two leading causes...
Eppendorf expanded its centrifuge offering with the acquisition of the centrifugation business of the Japanese company Koki Holdings Co Ltd whose products are marketed globally under the brand name Himac in The introduction of the portfolio under th...
Global contract development and manufacturing organisation CDMO Recipharm in charge of shaping the new entity SENSYO Pharmatech has attended a ceremony to recognise the launch of construction works at its new fill finish factory in Morocco The ceremo...
Calliditas Therapeutics AB today announced the commercial availability and initial sales of TARPEYO budesonide the first and only FDA approved treatment for IgA nephropathy indicated for reduction of proteinuria in adults with primary IgA nephropathy...
Atai Life Sciences NV a clinicalstage biopharmaceutical company aiming to transform the treatment of mental health disorders today launched Invyxis a new wholly owned platform company committed to developing new chemical entities NCEs and to further...
NeuroSense Therapeutics Ltd a company developing treatments for neurodegenerative diseases announced today the initiation of the third stage of a collaborative biomarker study with Massachusetts General Hospital MGH The extension of this collaborativ...
Ocugen Inc a biopharmaceutical company focused on discovering developing and commercializing breakthrough gene therapies and vaccines announced that it has signed a nonbinding letter of intent LOI with Liminal BioSciences Inc a Canadian public compan...
ALX Oncology Holdings Inc ALX Oncology a clinicalstage immunooncology company developing therapies that block the CD checkpoint pathway today announced that the US Food and Drug Administration FDA granted orphan drug designation ODD to evorpacept a n...
